Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL419613

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CNC1=C2C[C@@H](C)C[C@H](OC)[C@H](NCc3ccccc3)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O

Basic Information

ChEMBL ID CHEMBL419613
Phase Preclinical
Structure Type MOL
InChI Key HXRZWVSVRLWOQU-WDKUFWOVSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

648.8
MW (Da)
3.78
ALogP
9
HBA
4
HBD
158.1
PSA (Ų)
0.26
QED
1
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C36H48N4O7
MW 648.80
Aromatic Rings 1
Heavy Atoms 47
NP-Likeness 1.76

Activity Summary

IC50 1 meas. best 6.07

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 6.07 6.07 850.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 850.0 nM 6.07 In vitro inhibition of p185 erbB-2 oncoprotein in human breast cancer SK-BR-3 ce... 7562912

Literature References

PubMed DOI Target Context # Activities
7562912 10.1021/jm00019a011 SK-BR-3 1

Data from ChEMBL 36 via Core Engine